Abstract:Background Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) is a reliable treatment for actinic keratosis (AK), but its effect needs to be enhanced in thick lesions. Plum-blossom needle is a traditional Chinese cost-effective instrument for enhancing the transdermal delivery of ALA. However, whether it could improve the efficacy of AK treatment has not yet been investigated. Objective To compare the efficacy and safety of plum-blossom needle–assisted PDT in facial AK in the Chinese population. Methods In this multicenter, prospective study, a total of 142 patients with AKs (grades I–III) were randomized into the plum-blossom needle–assisted PDT group (P-PDT) and control PDT group (C-PDT). In the P-PDT group, each AK lesion was tapped vertically by a plum-blossom needle before the application of 10% ALA cream. In the C-PDT group, each lesion was only wiped with regular saline before ALA cream incubation. Then, 3 hours later, all the lesions were irradiated with light-emitting diode (LED) at a wavelength of 630 nm. PDT was performed once every 2 weeks until all lesion patients achieved complete remission or completed six sessions. The efficacy (lesion response) and safety (pain scale and adverse events) in both groups were evaluated before each treatment and at every follow-up visit at 3-month intervals until 12 months. Results In the P-PDT and C-PDT groups, the clearance rates for all AK lesions after the first treatment were 57.9% and 48.0%, respectively ( P < 0.05). For grade I AK lesions, the clearance rates were 56.5% and 50.4%, respectively ( P = 0.34). For grade II AK lesions, the clearance rates were 58.0% and 48.9%, respectively ( P = 0.1). For grade III AK lesions, the clearance rates were 59.0% and 44.2%, respectively ( P < 0.05). Moreover, grade III AK lesions in the P-PDT group required fewer treatment sessions ( P < 0.05). There was no significant difference in the pain score between the two groups ( P = 0.752). Conclusion Plum-blossom needle tapping may enhance the efficacy of ALA-PDT by facilitating ALA delivery in the treatment of AK.

Modified Painless Photodynamic Therapy for Actinic Keratosis in China

Modified painless photodynamic therapy for facial multiple actinic keratosis in China: A prospective split‐face control study

Conventional Versus Daylight Photodynamic Therapy for Actinic Keratosis: A Randomized and Prospective Study in China

Plum-blossom needle tapping enhances the efficacy of ALA photodynamic therapy for facial actinic keratosis in Chinese population: a randomized, multicenter, prospective, and observer-blind study

Topical Photodynamic Therapy with Different Forms of 5-Aminolevulinic Acid in the Treatment of Actinic Keratosis

Comparison of Efficacy, Adverse Effects and Costs Between 20 % ALA-PDT and 10 % ALA-PDT for the Treatment of Actinic Keratosis in Chinese Patients

Therapeutic and fluorescence evaluation of 20% 5-aminolevulinic acid-mediated photodynamic therapy in actinic keratosis

5-Aminolaevulinic acid-based photodynamic therapy for actinic keratosis in Chinese patients: A prospective multicenter study

Photodynamic therapy light': An enhanced treatment protocol for actinic keratoses with minimal pain and optimal clinical outcome by combining laser-assisted low irradiance PDT with shortened daylight PDT

Modified 5‐aminolevulinic Acid Photodynamic Therapy Reduces Pain and Improves Therapeutic Effects in Cutaneous Squamous Cell Carcinoma Mouse Model

Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial

Long-term Improvement on Photoaging after ALA Photodynamic Therapy for Actinic Keratosis: A Retrospective Study.

Advances in Photodynamic Therapy for the Treatment of Actinic Keratosis and Nonmelanoma Skin Cancer: A Narrative Review

Efficacy and safety of microneedling, fractional CO2 laser, and cryotherapy combined with 5-aminolevulinic acid photodynamic therapy in the treatment of actinic keratosis: A multicenter prospective randomized controlled study

Assessment of 5‐aminolaevulinic Acid Photodynamic Therapy (ALA‐PDT) in Chinese Patients with Actinic Keratosis: Correlation of Dermoscopic Features with Histopathology

Photodynamic Therapy with 5-Aminolevulinic Acid Patch for the Treatment of Actinic Keratosis

Application of 5‐aminolevulinic Acid‐photodynamic Therapy in Common Skin Diseases

Evaluation of Photodynamic Therapy of Skin Cancers with Partial Differential Alpha-Aminolevulinic Acid.

Home- vs clinic-based daylight photodynamic therapy with 5-aminolevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study

Effective treatment of actinic keratosis on the hands with red light photodynamic therapy using BF-200 ALA

Adverse Reactions of ALA-PDT for the Treatment of Cutaneous Diseases: A Retrospective Study.